Monthly Archives: July 2023

Introduction…. ”Suicide is the tenth leading cause of death in North America, and the leading cause in those aged 15–24 years worldwide [1]. For every adult who dies by suicide, more than 20 others attempt it [2]. Among the modifiable … Continue reading →

https://www.nature.com/articles/s41586-023-06331-x

Infections can lead to persistent or long-term symptoms and diseases such as shingles after varicella zoster, cancers after human papillomavirus, or rheumatic fever after streptococcal infections(1,2). Similarly, infection by SARS-CoV-2 can result in Long COVID, a condition characterized by symptoms … Continue reading →

Multiple sclerosis is characterised by the chronic inflammatory destruction of myelinated axons in the central nervous system. Several ideas have been put foward to clarify the roles of the peripheral immune system and neurodegenerative events in such destruction. Yet, none … Continue reading →

Abstract: The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has resulted in a serious public health burden worldwide. In addition to respiratory, heart, and gastrointestinal symptoms, patients infected with SARS-CoV-2 experience a … Continue reading →

https://kpe.utoronto.ca/faculty-news/kpe-says-goodbye-roy-shephard-world-renowned-authority-field-physical-activity-and https://doi.org/10.14288/hfjc.v4i3.118

Abstract Introduction: Major depressive disorder (MDD) is associated with low-grade inflammation, and anti-inflammatory treatment can help improve depressive symptoms. A recent study found that fluvoxamine (FLV) can reduce Interleukin-6 (IL-6) production via sigma-1 receptor in inflammation models. However, the anti- … Continue reading →